Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) will report its next earnings on Feb 7 – Feb 13 (Est.). The company reported the earnings of $-0.34/Share in the last quarter where the estimated EPS by analysts was $-0.2/share. The difference between the expected and actual EPS was $-0.14/share, which represents an Earnings surprise of -70%.
Many analysts are providing their Estimated Earnings analysis for Arrowhead Pharmaceuticals, Inc. and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-0.18/share. These analysts have also projected a Low Estimate of $-0.21/share and a High Estimate of $-0.15/share.
In case of Revenue Estimates, 2 analysts have provided their consensus Average Revenue Estimates for Arrowhead Pharmaceuticals, Inc. as 19.84 Million. According to these analysts, the Low Revenue Estimate for Arrowhead Pharmaceuticals, Inc. is 4.38 Million and the High Revenue Estimate is 35.3 Million. The company had Year Ago Sales of 44 Million.
Some buy side analysts are also providing their Analysis on Arrowhead Pharmaceuticals, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 6 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 5 Analysts reported that the Price Target for Arrowhead Pharmaceuticals, Inc. might touch $2 high while the Average Price Target and Low price Target is $1.8 and $1 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Arrowhead Pharmaceuticals, Inc. got Downgrade on 30-Nov-16 where investment firm William Blair Downgrade the stock from Outperform to Mkt Perform.
Arrowhead Pharmaceuticals, Inc. closed its last trading session at $1.89 with the gain of 6.88%. The Market Capitalization of the company stands at 122.33 Million. The Company has 52-week high of $8.22 and 52-week low of $1.2. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 36.95% where SMA50 and SMA200 are -34.44% and -62.46% respectively. The Company Touched its 52-Week High on Aug 24, 2016 and 52-Week Low on Dec 21, 2016.
The Relative Volume of the company is 1.49 and Average Volume (3 months) is 1.86 million. Arrowhead Pharmaceuticals, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of -77.9%. The Return on Equity (ROE) value stands at -101.2%. While it’s Return on Investment (ROI) value is -83.2%.
While looking at the Stock’s Performance, Arrowhead Pharmaceuticals, Inc. currently shows a Weekly Performance of 20.24%, where Monthly Performance is 47.45%, Quarterly performance is -72.1%, 6 Months performance is -65.47% and yearly performance percentage is -59.92%. Year to Date performance value (YTD perf) value is 30.32%. The Stock currently has a Weekly Volatility of 14.36% and Monthly Volatility of 10.31%.